文献速递头颈儿科影像技术与安全MR

定量磁共振影像组学预测视网膜母细胞瘤光感受器状态

Quantitative magnetic resonance imaging radiomics predicts photoreceptorness status in retinoblastoma.
PubMed 文献 · Pediatr Radiol · 2026-08-05

对全瘤分割后提取影像组学特征,最佳模型为递归特征消除加随机森林。训练队列交叉验证AUC为0.83,独立测试队列预测光感受器性丧失的AUC为0.81(95%CI 0.54-1.00)。

要点

  • 治疗前T2WI影像组学对识别光感受器性丧失有中等至良好区分力
  • 光感受器性反映光感受器相关基因表达与肿瘤分化状态
  • 结果提示影像组学可能为个体化治疗策略提供分子分化相关信息

核心结论

  • 定量MRI影像组学在无创预测视网膜母细胞瘤光感受器性状态方面显示出初步的中等至良好区分效能

研究设计与样本

  • 纳入条件为同时具有治疗前T2加权磁共振成像和全基因组信使RNA表达数据
  • 训练队列29例,独立测试队列16例,中位年龄18个月(范围2-70),女性18例
  • 全瘤分割后使用PyRadiomics提取影像组学特征,多机器学习流程经重复分层交叉验证评估

关键影像表现/征象

  • 分析的影像对象为治疗前T2加权磁共振成像上的视网膜母细胞瘤全瘤分割区域

诊断标准与关键数值

  • 最佳模型使用递归特征消除结合随机森林分类器
  • 训练队列平均交叉验证AUC为0.83
  • 独立测试队列预测光感受器性丧失的AUC为0.81,95%置信区间为0.54-1.00
  • 肿瘤按光感受器性最高与最低四分位数进行分析

临床应用与阅片要点

  • 提示治疗前常规T2WI可提取影像组学特征用于分子分化状态的无创评估
  • 影像组学流程需对肿瘤进行全瘤分割并采用可重复的特征提取方法

局限性

  • 原文未报告具体局限性条目

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Molecular characteristics of retinoblastoma cannot be assessed before treatment because tumor biopsy is contraindicated. Photoreceptorness reflects photoreceptor-related gene expression and tumor differentiation. Non-invasive imaging biomarkers that capture this biology are therefore needed.

OBJECTIVE: To evaluate whether quantitative radiomics derived from pretreatment magnetic resonance imaging can predict loss of photoreceptorness in retinoblastoma and validate this approach in an independent cohort.

MATERIALS AND METHODS: In this retrospective multicenter study, patients with retinoblastoma who underwent primary enucleation and had both pretreatment T2-weighted magnetic resonance imaging and genome-wide messenger RNA expression data were included. Tumors in the highest and lowest photoreceptorness quartiles were analyzed. Whole-tumor segmentations were used to extract radiomic features with PyRadiomics. Multiple machine-learning pipelines were evaluated using repeated stratified cross-validation, and the best-performing model was tested in an independent cohort.

RESULTS: Forty-five patients (median age, 18 months [range, 2-70], 18 female) were included: 29 in the training cohort and 16 in the independent testing cohort. The best-performing model used recursive feature elimination with a random forest classifier and achieved a mean cross-validated area under the receiver operating characteristic curve of 0.83 in the training cohort. In the independent testing cohort, the model achieved an area under the receiver operating characteristic curve of 0.81 (95% confidence interval, 0.54-1.00) for predicting loss of photoreceptorness.

CONCLUSION: Quantitative magnetic resonance imaging radiomics showed preliminary moderate-to-good discriminatory performance for non-invasively predicting photoreceptorness status in retinoblastoma. These proof-of-concept findings suggest that radiomics may capture imaging features related to molecular tumor differentiation and could support the development of personalized treatment strategies.

来源:Pediatr Radiol,查看原文。版权归原作者所有。

引用

  1. de Bloeme, Jansen, Uner, et al. Quantitative magnetic resonance imaging radiomics predicts photoreceptorness status in retinoblastoma. Pediatr Radiol. 2026. PMID: 42554833. doi:10.1007/s00247-026-06728-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。